Position in NBIX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,685
-$159 QoQ
Shares Held
10
-28.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#740
of 768 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BFSG, LLC holds $456,423 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
8,842 | $217,601 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,567 | $154,729 | |
| 3 | BHC |
Bausch Health Companies Inc.
|
14,905 | $73,481 | |
| 4 | VTRS |
Viatris Inc
|
500 | $7,940 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
10 | $1,685 | |
| 6 | TLRY |
Tilray Brands, Inc.
|
200 | $898 | |
| 7 | ACB |
Aurora Cannabis Inc
|
32 | $89 |
All Filings in NBIX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,685 | 10 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,844 | 14 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,985 | 14 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $1,965 | 14 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,136 | 17 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,880 | 17 | Shares | Sole | 2025-04-18 | |
| No filing history on record for this holder in this stock. | ||||||